Skip to main content
Clinical Trials/JPRN-UMIN000042203
JPRN-UMIN000042203Completed未知

Investigation of factors affecting patients' preference of biologics treatment modes with rheumatoid arthritis - Investigation of factors affecting patients' preference of biologics treatment modes with rheumatoid arthritis

Mitsubishi Tanabe Pharma Corporation0 sites400 target enrollmentStarted: October 22, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
400